Ute I Schwarz

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Positive Breast Cancer

Acute Lymphoblastic Leukemia

Top Venues

Clinical pharmacology and therapeutics

BMC medical genomics

Journal of thrombosis and thrombolysis

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Samantha Medwid, Ute I Schwarz, Yun-Hee Choi, Denise Keller, Cameron Ross, Richard B Kim
Solanidine Metabolites as Diet-Derived Biomarkers of CYP2D6-Mediated Tamoxifen Metabolism in Breast Cancer Patients. Clinical pharmacology and therapeutics (2024)
Ute I Schwarz, Morgan Woldanski-Travaglini, Valerie Swanston, Mariam Mikhail, Chantel Cacciotti, Elizabeth Cairney, Serina Patel, Jennifer Seelisch, Soumitra Tole, Marta Wilejto, Rommel G Tirona, Richard B Kim, Alexandra P Zorzi
TPMT intermediate metabolizer status and thiopurine-associated toxicity during maintenance therapy in childhood acute lymphoblastic leukemia. Clinical pharmacology and therapeutics (2023)
Markus Gulilat, Denise Keller, Bradley Linton, A Demetri Pananos, Daniel Lizotte, George K Dresser, Jeffrey Alfonsi, Rommel G Tirona, Richard B Kim, Ute I Schwarz
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care. Journal of thrombosis and thrombolysis 49 (2) (2020)
Laura E Russell, Ute I Schwarz
Variant discovery using next-generation sequencing and its future role in pharmacogenetics. Pharmacogenomics 21 (7) (2020)
Markus Gulilat, Tyler Lamb, Wendy A Teft, Jian Wang, Jacqueline S Dron, John F Robinson, Rommel G Tirona, Robert A Hegele, Richard B Kim, Ute I Schwarz
Targeted next generation sequencing as a tool for precision medicine. BMC medical genomics 12 (1) (2019)